Biosimilar uptake will take more than competitive pricing

European Pharmaceutical Review provides up-to-date information and statistics regarding drug analysis, formulation, delivery, manufacturing and regulation. They have been distributing facts, analysis and statistics for over 20 years and have cultivated some particularly strong relationships with widely-recognised figures in the life science community. European Pharmaceutical Review is customarily distributed to senior personnel of the drug discovery, delivery and distribution service communities, both in Europe and the US.

George I’ons is our Head of Product Strategy and Insights here at Owen Mumford Pharmaceutical Services and, once again, he’s written an insightful, informative and instructive article. This time, George talks us through how pharmaceutical companies could help encourage injectable biosimilar uptake, especially to compete with their reference biologics. Securing a share in this competitive market is increasingly attractive as patents on key biologics expire, so read below to learn how to catapult your injectable biosimilar to a higher status